Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayako Michino

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Biochemical Pharmacology|January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptorChristopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Journal of Medicinal Chemistry|April 2, 2016
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist SelectivityMu-Fa Zou, Thomas M Keck, Vivek Kumar, et al.
Scientific Reports|January 21, 2018
The action of a negative allosteric modulator at the dopamine D<sub>2</sub> receptor is dependent upon sodium ionsChristopher J Draper-Joyce, Ravi Kumar Verma, Mayako Michino, et al.
Journal of Medicinal Chemistry|December 17, 2016
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D<sub>3</sub> ReceptorMayako Michino, Comfort A Boateng, Prashant Donthamsetti, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual ScreeningCindy Meyer, Mayako Michino, David J Huggins, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
A Chemical Strategy toward Novel Brain-Penetrant EZH2 InhibitorsRui Liang, Daisuke Tomita, Yusuke Sasaki, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable <i>In Vivo</i> Studies: Discovery of TDI-11055Mayako Michino, Tanweer A Khan, Michael W Miller, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|January 13, 2018
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D<sub>2</sub> receptorChristopher J Draper-Joyce, Mayako Michino, Ravi Kumar Verma, et al.
Journal of Medicinal Chemistry|April 2, 2016
Novel Analogues of (R)-5-(Methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (Sumanirole) Provide Clues to Dopamine D2/D3 Receptor Agonist SelectivityMu-Fa Zou, Thomas M Keck, Vivek Kumar, et al.
Scientific Reports|January 21, 2018
The action of a negative allosteric modulator at the dopamine D<sub>2</sub> receptor is dependent upon sodium ionsChristopher J Draper-Joyce, Ravi Kumar Verma, Mayako Michino, et al.
Journal of Medicinal Chemistry|December 17, 2016
Toward Understanding the Structural Basis of Partial Agonism at the Dopamine D<sub>3</sub> ReceptorMayako Michino, Comfort A Boateng, Prashant Donthamsetti, et al.
ACS Medicinal Chemistry Letters|September 17, 2025
Discovery of Novel Isofunctional SARS-CoV‑2 NSP14 RNA Cap Methyltransferase Inhibitors by Structure-Based Virtual ScreeningCindy Meyer, Mayako Michino, David J Huggins, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
A Chemical Strategy toward Novel Brain-Penetrant EZH2 InhibitorsRui Liang, Daisuke Tomita, Yusuke Sasaki, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Bioorganic & Medicinal Chemistry Letters|July 23, 2019
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cellsEdouard Mullarky, Jiayi Xu, Anita D Robin, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable <i>In Vivo</i> Studies: Discovery of TDI-11055Mayako Michino, Tanweer A Khan, Michael W Miller, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Pageof 4